Armata Pharmaceuticals (ARMP) Debt to Equity (2018 - 2026)
Armata Pharmaceuticals' (ARMP) quarterly Debt to Equity came in at -$0.28 in Q1 2026, up 45.17% year-on-year from -$0.19 in Q1 2025, and up 40.11% quarter-over-quarter from -$0.47 in Q4 2025.
Armata Pharmaceuticals (ARMP) Debt to Equity (2018 - 2026) Analysis & Trends
Armata Pharmaceuticals has disclosed Debt to Equity across 7 years of filings, most recently posting -$0.28 for Q1 2026.
- Debt to Equity for Q1 2026 came in at -$0.28, up 45.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.28 (up 45.17% YoY), and the FY2025 annual result was -$0.47, changed 0.45% from the prior year.
- Debt to Equity came in at -$0.28 for Q1 2026 at Armata Pharmaceuticals, up from -$0.47 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.28 in Q1 2026 to a low of -$1.89 in Q1 2024.
- The 4-year median for Debt to Equity is -$0.66 (2025), against an average of -$0.83.
- Peak annual rise in Debt to Equity reached 72.81% in 2025, while the deepest fall reached 0.45% in 2025.
- Armata Pharmaceuticals' Debt to Equity stood at -$0.74 in 2023, then soared by 36.43% to -$0.47 in 2024, then fell by 0.45% to -$0.47 in 2025, then jumped by 40.11% to -$0.28 in 2026.
- The last three Debt to Equity figures came in at -$0.28 (Q1 2026), -$0.47 (Q4 2025), and -$0.66 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28 |
| Dec 31, 2025 | -0.47 |
| Sep 30, 2025 | -0.66 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.51 |
| Dec 31, 2024 | -0.47 |
| Sep 30, 2024 | -0.81 |
| Jun 30, 2024 | -1.05 |
| Mar 31, 2024 | -1.89 |
| Dec 31, 2023 | -0.74 |
| Sep 30, 2023 | -1.80 |
| Dec 31, 2020 | 0.10 |
| Sep 30, 2020 | 0.07 |
| Jun 30, 2020 | 0.05 |
| Mar 31, 2020 | 0.04 |
| Dec 31, 2019 | 0.07 |
| Sep 30, 2019 | 0.05 |
| Jun 30, 2019 | 0.03 |
| Dec 31, 2018 | 0.13 |